Compare HOV & THQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HOV | THQ |
|---|---|---|
| Founded | 1959 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Finance Companies |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 726.0M | 784.0M |
| IPO Year | 1994 | N/A |
| Metric | HOV | THQ |
|---|---|---|
| Price | $119.16 | $18.91 |
| Analyst Decision | Sell | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $97.00 | N/A |
| AVG Volume (30 Days) | 102.8K | ★ 119.9K |
| Earning Date | 05-19-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 7.53% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.55 | N/A |
| Revenue | ★ $2,978,581,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.96 | N/A |
| P/E Ratio | $74.79 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $91.52 | $16.28 |
| 52 Week High | $162.06 | $20.39 |
| Indicator | HOV | THQ |
|---|---|---|
| Relative Strength Index (RSI) | 43.10 | 44.76 |
| Support Level | $107.68 | $18.89 |
| Resistance Level | $127.03 | $19.41 |
| Average True Range (ATR) | 4.05 | 0.28 |
| MACD | -0.76 | -0.12 |
| Stochastic Oscillator | 28.51 | 26.53 |
Hovnanian Enterprises Inc conducts all of its homebuilding and financial services operations. The company designs, constructs, markets, and sells single-family detached homes, attached townhomes and condominiums, urban infill, and active lifestyle homes in planned residential developments. It has two distinct operations: homebuilding and financial services. Its homebuilding operations are divided geographically into three segments: Northeast, which includes Delaware, Maryland, New Jersey, Ohio, Pennsylvania, Virginia, and West Virginia; Southeast, which includes Florida, Georgia, and South Carolina; and West, which includes Arizona, California, and Texas. The firm generates maximum revenue from the West Segment.
abrdn Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. Its investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies. The fund invests in equity and debt securities of public and private healthcare companies believed by the Fund's Adviser to have potential for above-average growth, and may invest in private companies and other restricted securities, including private investments in public equity and venture capital investments, provided these securities comprise 10% or less of Managed Assets.